DNA vaccination

Results: 172



#Item
1Pioneering the Development of Safe and Effective Non-Viral Vectors and Processes for Human Gene Therapy and DNA Vaccination. Founded 1999, Clague Hodgson, Ph.D. Chief Scientific Officer, VP, R&D, Jim Williams, Ph.D. (200

Pioneering the Development of Safe and Effective Non-Viral Vectors and Processes for Human Gene Therapy and DNA Vaccination. Founded 1999, Clague Hodgson, Ph.D. Chief Scientific Officer, VP, R&D, Jim Williams, Ph.D. (200

Add to Reading List

Source URL: natx.com

Language: English - Date: 2018-01-08 14:40:54
    2Microsoft PowerPoint - Flyer pDNA

    Microsoft PowerPoint - Flyer pDNA

    Add to Reading List

    Source URL: www.biomay.com

    Language: English - Date: 2012-03-13 12:50:23
    3Microsoft Word - jiu511.doc

    Microsoft Word - jiu511.doc

    Add to Reading List

    Source URL: www.scsml.rssi.ru

    Language: English - Date: 2014-10-03 03:42:18
    4SUPPLEMENT ARTICLE  Kunjin Virus Replicon-Based Vaccines Expressing Ebola Virus Glycoprotein GP Protect the Guinea Pig Against Lethal Ebola Virus Infection

    SUPPLEMENT ARTICLE Kunjin Virus Replicon-Based Vaccines Expressing Ebola Virus Glycoprotein GP Protect the Guinea Pig Against Lethal Ebola Virus Infection

    Add to Reading List

    Source URL: www.scsml.rssi.ru

    Language: English - Date: 2014-10-03 05:48:26
    5Pioneering the Development of Safe and Effective Non-Viral Vectors and Processes for Human Gene Therapy and DNA Vaccination. • Founded 1999, Clague Hodgson, Ph.D. • Chief Scientific Officer, VP, R&D, Jim Williams, Ph

    Pioneering the Development of Safe and Effective Non-Viral Vectors and Processes for Human Gene Therapy and DNA Vaccination. • Founded 1999, Clague Hodgson, Ph.D. • Chief Scientific Officer, VP, R&D, Jim Williams, Ph

    Add to Reading List

    Source URL: www.natx.com

    Language: English - Date: 2015-10-12 10:14:08
      6Improved immunomodulators for improved vaccines WP5.3: Adjuvants and Immunomodulators Adjuvants should be: non-toxic, potent, stable, well-defined, specific*, versatile, economical *specific actions: e.g. mucosal stimula

      Improved immunomodulators for improved vaccines WP5.3: Adjuvants and Immunomodulators Adjuvants should be: non-toxic, potent, stable, well-defined, specific*, versatile, economical *specific actions: e.g. mucosal stimula

      Add to Reading List

      Source URL: www.epizone-eu.net

      Language: English - Date: 2014-03-25 09:36:26
      7In Cell Art and Merial enter into a research collaboration agreement Nantes – France, 9 November, 2010 – IN CELL ART, a biotechnology company involved in macromolecular drug (siRNA, DNA) delivery systems, has announc

      In Cell Art and Merial enter into a research collaboration agreement Nantes – France, 9 November, 2010 – IN CELL ART, a biotechnology company involved in macromolecular drug (siRNA, DNA) delivery systems, has announc

      Add to Reading List

      Source URL: i.message-business.com

      Language: English - Date: 2010-11-09 09:19:41
      8A Primer on the Role of ImmBio’s Vaccines Approaches There are two broad approaches to infectious disease management, beyond hygiene measures:   Treatment by drug therapy

      A Primer on the Role of ImmBio’s Vaccines Approaches There are two broad approaches to infectious disease management, beyond hygiene measures:  Treatment by drug therapy

      Add to Reading List

      Source URL: www.immbio.com

      Language: English - Date: 2013-04-02 07:17:13
      9Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma

      Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma

      Add to Reading List

      Source URL: www.biomedcentral.com

      Language: English
      10The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 24 April 2001 CPMP/BWP

      The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 24 April 2001 CPMP/BWP

      Add to Reading List

      Source URL: www.ema.europa.eu

      Language: English - Date: 2013-07-21 04:57:47